DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Tofacitinib (Xeljanz) ( DrugBank:
Tofacitinib
)
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
46
悪性関節リウマチ
1
46. 悪性関節リウマチ
臨床試験数
:
4,325
/
薬物数
:
2,671
- (
DrugBank
:
417
) /
標的遺伝子数
:
187
-
標的パスウェイ数
:
224
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT01932372
(
ClinicalTrials.gov
)
July 26, 2013
30/7/2013
Tofacitinib (Xeljanz)
Special Investigation for Rheumatoid Arthritis
XELJANZ (REGISTERED) TABLETS 5MG SPECIAL INVESTIGATION (ALL-CASES SURVEILLANCE)
Rheumatoid Arthritis
Drug:
Tofacitinib (Xeljanz)
;Drug: Etanercept, other Biologics, Disease-modifying antirheumatic drugs (DMARDs), etc
Drug:
Tofacitinib (Xeljanz)
;Drug: Etanercept, other Biologics, Disease-modifying antirheumatic drugs ...
Pfizer
NULL
Completed
N/A
N/A
All
9968
Japan